Virax Biolabs Group Limited (VRAX)

$0.15 +0.01 (9.64%)
Market Cap 608,000.00
Revenue (ttm) 10,000.00
Net Income (ttm) -6.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -60,600.00%
Debt to Equity Ratio 0.04
Volume 1,726,500
Avg Vol 17,198,064
Day's Range N/A - N/A
Shares Out 4.34M
Stochastic %K 48%
Beta 1.06
Analysts Sell
Price Target $1.00

Company Profile

Virax Biolabs Group Limited, a biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics. The company offers various in-vitro diagnostics test kits comprising respiratory, pregnancy and fertility, infectious diseases, sti, drugs of abuse, oncology, cardiac, women's health, other test kits under the ViraxClear brands; and rapid and molecular tests for small animal veterinary...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 20 7788 7414
Address:
BioCity Glasgow, Bo’Ness Road Newhouse, Lanarkshire, United Kingdom
DipBuyInvester
DipBuyInvester May. 16 at 12:57 AM
$VRAX Baby don
0 · Reply
Tigerlilly11
Tigerlilly11 May. 15 at 9:50 PM
$VRAX Talk about "emotional trading"... The Bear who is shorting this keeps shorting 1000s of shares in the lower .14s, only to have the Bid go immediately to .15 So, his "buy to cover" is immediately negative profits... And this is when the stock not only broke the downtrend, but reversed from near its all time lower support levels. There is ZERO reason to be shorting down here... Especially in the face of great PR around the corner. Very Bullish
1 · Reply
dogood
dogood May. 15 at 8:46 PM
$VRAX look at this $TRAW goifn to break $2
0 · Reply
dogood
dogood May. 15 at 8:46 PM
$VRAX I want her to hit .20 then next week she could hit $.30
1 · Reply
Drewrr
Drewrr May. 15 at 8:45 PM
$VRAX might blow here.
0 · Reply
topstockalerts
topstockalerts May. 15 at 8:42 PM
$VRAX buyers appear to be in full control right now
0 · Reply
dogood
dogood May. 15 at 8:31 PM
$VRAX TRAw went higher shall we hit .20
0 · Reply
luminouslumens
luminouslumens May. 15 at 8:25 PM
$VRAX $TRAW Both at HOD, hantavirus news over the weekend? 🧐
0 · Reply
dogood
dogood May. 15 at 8:24 PM
$VRAX break .20
0 · Reply
dogood
dogood May. 15 at 7:19 PM
$VRAX .18 please
0 · Reply
Latest News on VRAX
Virax Biolabs CEO outlines strategic priorities, near-term milestones

2026-04-14T11:58:17.000Z - 4 weeks ago

Virax Biolabs CEO outlines strategic priorities, near-term milestones

Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders

Apr 14, 2026, 7:34 AM EDT - 4 weeks ago

Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders

Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation

Mar 31, 2026, 7:34 AM EDT - 6 weeks ago

Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation

Virax Biolabs price target lowered to $1 from $3 at H.C. Wainwright

2026-01-09T17:26:12.000Z - 4 months ago

Virax Biolabs price target lowered to $1 from $3 at H.C. Wainwright

Virax Biolabs files to sell 25.875M ordinary shares for holders

2025-12-18T21:15:19.000Z - 5 months ago

Virax Biolabs files to sell 25.875M ordinary shares for holders

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement

Dec 4, 2025, 4:05 PM EST - 5 months ago

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement

Virax Biolabs Group Limited Announces $5 Million Private Placement

Dec 3, 2025, 1:53 PM EST - 5 months ago

Virax Biolabs Group Limited Announces $5 Million Private Placement

Why Is Virax Biolabs (VRAX) Stock Rocketing Higher Today?

2025-12-03T13:54:57.000Z - 5 months ago

Why Is Virax Biolabs (VRAX) Stock Rocketing Higher Today?

Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders

Dec 3, 2025, 7:34 AM EST - 5 months ago

Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders

Virax completes patient recruitment for its clinical study evaluating ViraxImmun

2025-11-03T13:36:20.000Z - 6 months ago

Virax completes patient recruitment for its clinical study evaluating ViraxImmun

Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes

Nov 3, 2025, 8:29 AM EST - 6 months ago

Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes

Virax Biolabs partners with Emory University on ViraxImmune clinical studies

2025-08-26T11:35:28.000Z - 9 months ago

Virax Biolabs partners with Emory University on ViraxImmune clinical studies

Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September

Aug 26, 2025, 7:30 AM EDT - 9 months ago

Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September

Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy

Jul 29, 2025, 7:35 AM EDT - 10 months ago

Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy

Virax Biolabs receives noncompliance notice from Nasdaq

2025-07-19T02:25:41.000Z - 10 months ago

Virax Biolabs receives noncompliance notice from Nasdaq

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Jul 18, 2025, 4:15 PM EDT - 10 months ago

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Virax Biolabs initiated with a Buy at H.C. Wainwright

2025-03-31T10:15:46.000Z - 1 year ago

Virax Biolabs initiated with a Buy at H.C. Wainwright

Virax Biolabs enrolls first patients in T-cell dysfunction study

2025-03-18T11:36:57.000Z - 1 year ago

Virax Biolabs enrolls first patients in T-cell dysfunction study

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Mar 18, 2025, 7:30 AM EDT - 1 year ago

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Mar 13, 2025, 7:30 AM EDT - 1 year ago

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Mar 5, 2025, 7:30 AM EST - 1 year ago

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Feb 25, 2025, 7:00 AM EST - 1 year ago

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

Jan 23, 2025, 3:35 PM EST - 1 year ago

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

COSM

Cosmos Health secures exclusive distribution agreement with Virax Biolabs

2025-01-13T14:41:05.000Z - 1 year ago

Cosmos Health secures exclusive distribution agreement with Virax Biolabs

COSM

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

Jan 13, 2025, 9:20 AM EST - 1 year ago

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

COSM

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Dec 17, 2024, 7:30 AM EST - 1 year ago

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Virax Biolabs enters non-exclusive distribution agreement with Tebubio

2024-12-10T12:35:42.000Z - 1 year ago

Virax Biolabs enters non-exclusive distribution agreement with Tebubio

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Dec 10, 2024, 7:30 AM EST - 1 year ago

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Virax Biolabs announces distribution agreement with Europa Biosite

2024-10-23T11:35:15.000Z - 1 year ago

Virax Biolabs announces distribution agreement with Europa Biosite

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Oct 23, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Cosmos Health enters exclusivity agreement with Virax Biolabs

2024-09-23T13:20:29.000Z - 1 year ago

Cosmos Health enters exclusivity agreement with Virax Biolabs

COSM

Cosmos Health secures exclusivity agreement with Virax Biolabs

2024-09-16T12:50:07.000Z - 1 year ago

Cosmos Health secures exclusivity agreement with Virax Biolabs

COSM

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

Sep 16, 2024, 8:30 AM EDT - 1 year ago

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

COSM

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

Sep 16, 2024, 8:30 AM EDT - 1 year ago

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

COSM

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Sep 9, 2024, 8:00 AM EDT - 1 year ago

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Virax Biolabs to Participate at 7th European Congress of Immunology

Aug 29, 2024, 9:03 AM EDT - 1 year ago

Virax Biolabs to Participate at 7th European Congress of Immunology

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know

Aug 28, 2024, 2:18 PM EDT - 1 year ago

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Aug 28, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Virax Biolabs Group Ltd trading resumes

2024-08-26T14:15:31.000Z - 1 year ago

Virax Biolabs Group Ltd trading resumes

Virax Biolabs Group Ltd trading halted, volatility trading pause

2024-08-26T14:10:29.000Z - 1 year ago

Virax Biolabs Group Ltd trading halted, volatility trading pause

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Aug 23, 2024, 4:09 PM EDT - 1 year ago

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 9:30 PM EDT - 1 year ago

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

Aug 21, 2024, 10:20 AM EDT - 1 year ago

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

COSM

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Virax Biolabs to Participate at ESCMID Global 2024

Apr 16, 2024, 7:30 AM EDT - 2 years ago

Virax Biolabs to Participate at ESCMID Global 2024

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Dec 21, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Dec 14, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Sep 12, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Sep 1, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Aug 3, 2023, 7:30 AM EDT - 3 years ago

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

Jul 18, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

May 4, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Apr 19, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 10, 2023, 5:17 PM EST - 3 years ago

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 8, 2023, 8:55 AM EST - 3 years ago

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Mar 7, 2023, 7:30 AM EST - 3 years ago

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

Feb 7, 2023, 9:15 AM EST - 3 years ago

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

COSM

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

Feb 7, 2023, 8:30 AM EST - 3 years ago

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

COSM

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Feb 6, 2023, 4:05 PM EST - 3 years ago

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

Jan 4, 2023, 7:30 AM EST - 3 years ago

Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Dec 6, 2022, 7:30 AM EST - 3 years ago

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Nov 15, 2022, 7:30 AM EST - 3 years ago

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement

Nov 8, 2022, 4:30 PM EST - 3 years ago

Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement

Virax Biolabs Group Limited Announces $3.8 Million Private Placement

Nov 4, 2022, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Announces $3.8 Million Private Placement

Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

Nov 3, 2022, 7:30 AM EDT - 3 years ago

Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

Oct 26, 2022, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

DipBuyInvester
DipBuyInvester May. 16 at 12:57 AM
$VRAX Baby don
0 · Reply
Tigerlilly11
Tigerlilly11 May. 15 at 9:50 PM
$VRAX Talk about "emotional trading"... The Bear who is shorting this keeps shorting 1000s of shares in the lower .14s, only to have the Bid go immediately to .15 So, his "buy to cover" is immediately negative profits... And this is when the stock not only broke the downtrend, but reversed from near its all time lower support levels. There is ZERO reason to be shorting down here... Especially in the face of great PR around the corner. Very Bullish
1 · Reply
dogood
dogood May. 15 at 8:46 PM
$VRAX look at this $TRAW goifn to break $2
0 · Reply
dogood
dogood May. 15 at 8:46 PM
$VRAX I want her to hit .20 then next week she could hit $.30
1 · Reply
Drewrr
Drewrr May. 15 at 8:45 PM
$VRAX might blow here.
0 · Reply
topstockalerts
topstockalerts May. 15 at 8:42 PM
$VRAX buyers appear to be in full control right now
0 · Reply
dogood
dogood May. 15 at 8:31 PM
$VRAX TRAw went higher shall we hit .20
0 · Reply
luminouslumens
luminouslumens May. 15 at 8:25 PM
$VRAX $TRAW Both at HOD, hantavirus news over the weekend? 🧐
0 · Reply
dogood
dogood May. 15 at 8:24 PM
$VRAX break .20
0 · Reply
dogood
dogood May. 15 at 7:19 PM
$VRAX .18 please
0 · Reply
DipBuyInvester
DipBuyInvester May. 15 at 6:05 PM
$VRAX You will change the life baby!!
0 · Reply
Bigbas
Bigbas May. 15 at 5:42 PM
$VRAX so have I just got burnt when I was newer to the game but you do you man, I don’t have anything against ya but if I’m bad luck you aren’t any better lady
0 · Reply
Forsakentrades2024
Forsakentrades2024 May. 15 at 5:41 PM
$VRAX been long on fatn for a while avg up the other
0 · Reply
Bigbas
Bigbas May. 15 at 5:39 PM
$VRAX lost so now she is here trying to recoup losses 🤣
0 · Reply
dogood
dogood May. 15 at 5:38 PM
$EOSE I want to see $9 in $EOSE $WLDS $1.3 $VRAX $0.18 $GNPX $1 Before the weekend but not happening yet
0 · Reply
dogood
dogood May. 15 at 4:38 PM
$VRAX may be after he’s she runs to .20+ but meanwhile if she closes at .18 that is actually great win for the weekend
0 · Reply
dogood
dogood May. 15 at 4:17 PM
$VRAX Names of Reporting Persons Armistice Capital, LLC - 5%
0 · Reply
dogood
dogood May. 15 at 4:00 PM
$VRAX hit .20 go spike
0 · Reply
TraderBuckNKY
TraderBuckNKY May. 15 at 3:45 PM
$VRAX SEC Filing Alert for Virax Biolabs Group Limited
0 · Reply
GenX_Forever_Feral
GenX_Forever_Feral May. 15 at 3:19 PM
$TDIC GOING IN AT 1.12. $SNAL $VRAX
1 · Reply
TradeSticks_ThrowStones
TradeSticks_ThrowStones May. 15 at 3:14 PM
$VRAX So the company is clearly trying to improve awareness and attract investors.
0 · Reply
dogood
dogood May. 15 at 2:19 PM
$VRAX waiting for $.20 break
0 · Reply